natgillin/translations-raw huggingface dataset:
This section tells you how to mix the powder and the sterile water (solvent) together and then how to inject your medicine.
V tem poglavju boste našli navodila, kako zmešati prašek in sterilno vodo (vehikel) in kako injicirati zdravilo.
This section tells you how to use RebiDose.
To poglavje vam pove kako uporabljati peresnik RebiDose.
This self-limitation is likely due to the loss of dibotermin alfa from the application site, as well as the presence of BMP inhibitors in the surrounding tissues.
To samoomejevalno sposobnost gre verjetno pripisati izgubi dibotermina alfa z mesta implantacije, pa tudi prisotnosti inhibitorjev proteina za morfogenezo kosti (BMP – Bone Morphogenetic Protein) v okolnem tkivu.
This self-limitation is likely due to the loss of dibotermin alfa from the implant site, as well as the presence of BMP inhibitors in the surrounding tissues.
To samoomejevalno sposobnost gre verjetno pripisati izgubi dibotermina alfa z mesta implantacije, pa tudi prisotnosti inhibitorjev proteina za morfogenezo kosti (BMP – »Bone Morphogenetic Protein«) v okolnem tkivu.
This should be a fatty layer of skin.
Tako primete kožo skupaj s podkožnim maščevjem.
This should be a final volume of 50 ml.
To mora biti končni volumen (50 ml).
This should be borne in mind when administering azole antifungals (e.g. ketoconazole) or macrolide antibiotics (e.g. erythromycin) concurrently with oxybutynin.
To je treba upoštevati pri sočasni uporabi azolnih antimikotikov (npr. ketokonazola) ali makrolidnih antibiotikov (npr. eritromicina) in oksibutinina.
This should be borne in mind when planning vaccination programmes for calves, which receive Locatim.
Dejstvo je potrebno upoštevati pri načrtovanju programa zaščitnih cepljenj za teleta, ki so prejela Locatim.
This should be carried out by health care professionals.
Takšno dajanje mora opraviti zdravstveno osebje.
This should be considered during the preparation and administration of Torisel following constitution.
To morate upoštevati pri pripravi in uporabi zdravila Torisel.
This should be considered if co-administering oral CYP3A4/P-gp substrates for which retained efficacy is very important.
To je treba upoštevati, če sočasno dajemo peroralne substrate CYP3A4/P-gp, za katere je ohranjena učinkovitost zelo pomembna.
This should be considered if co-administering oral CYP3A4/Pgp substrates for which retained efficacy is very important.
To je treba upoštevati, če sočasno dajemo peroralne substrate CYP3A4/Pgp, za katere je ohranjena učinkovitost zelo pomembna.
This should be considered in advance of any procedures.
To je treba upoštevati pred vsemi posegi.
This should be considered in cases where full alertness is required, e.g., when driving a car or handling machines.
To je treba upoštevati kadar je potrebna popolna budnost in pozornost, npr. med vožnjo avtomobila ali pri upravljanju strojev.
This should be considered when assessing a patient's ability to drive or operate machinery.
To je treba upoštevati pri ocenjevanju bolnikove sposobnosti za vožnjo ali upravljanje s stroji.
This should be considered when assessing a patient’s ability to drive or operate machinery.
To je treba upoštevati pri ocenjevanju bolnikove sposobnosti vožnje ali upravljanja s stroji.
This should be considered when interpreting bone- imaging results.
To je treba upoštevati pri razlagi rezultatov slikanja kosti.
This should be considered when prescribing Senshio for postmenopausal women with a history of stroke or other significant stroke risk factors.
To je treba upoštevati pri predpisovanju zdravila Senshio ženskam po menopavzi z možgansko kapjo v anamnezi ali drugimi pomembnimi dejavniki za možgansko kap.
This should be considered when switching patients between pegylated and non-pegylated interferons.
To morate upoštevati, ko bolnikom menjujete terapijo s pegiliranim in nepegiliranim interferonom.
This should be considered when treating patients with impaired renal function since these events, i.e. nausea, vomiting, and/or diarrhoea, may cause dehydration which could cause a deterioration of renal function.
To je treba upoštevati pri zdravljenju bolnikov z okvarjenim delovanjem ledvic, saj ti dogodki, tj. slabost, bruhanje in/ali driska lahko povzročijo dehidracijo, ki bi lahko povzročila poslabšanje delovanja ledvic.
This should be discussed with your doctor (see “Do not take Ribavirin Teva Pharma B.V. ”).
O tem se lahko posvetujete z zdravnikom (glejte poglavje »Ne uporabljajte zdravila Ribavirin Teva Pharma B.V.«).
This should be discussed with your doctor (see “Do not take Ribavirin Teva Pharma B.V.”).
Pogovorite se o tem s svojim zdravnikom (glejte poglavje “Ne uporabljajte zdravila Ribavirin Teva Pharma B.V.”).
This should be discussed with your doctor.
Pogovorite se o tem z zdravnikom.
This should be discussed with your doctor.
Pogovorite se o tem z zdravnikom. če ste moški in jemljete ribavirin:
This should be done by genetic testing in an appropriate laboratory.
To se opravi z genetskim testiranjem v ustreznem laboratoriju.
This should be done in fasted condition and not before the following day.
Ta mora biti opravljen na tešče in ne pred naslednjim dnem.
This should be followed by oral prednisone 1 mg/kg/day (not to exceed 80 mg/day, and tapered as rapidly as possible based on clinical need) during and after MabThera treatment.
Temu mora slediti 1 mg/kg/dan prednizona peroralno (odmerek ne sme preseči 80 mg/dan in ga je treba zmanjšati, kolikor hitro je mogoče glede na klinične potrebe) med zdravljenjem z zdravilom MabThera in po njem.
This should be kept in mind if treatment with the combination of pioglitazone and Liprolog Basal is considered.
To je treba upoštevati pri načrtovanju zdravljenja s kombinacijo pioglitazona in zdravila Liprolog Basal.
This should be kept in mind if treatment with the combination of pioglitazone and Liprolog is considered.
To je treba upoštevati pri načrtovanju zdravljenja s kombinacijo pioglitazona in zdravila Liprolog.
This should be kept in mind if treatment with the combination of pioglitazone and Toujeo is considered.
To je potrebno upoštevati pri zdravljenju s kombinacijo pioglitazona in zdravila Toujeo.
This should be kept in mind, if treatment with the combination of pioglitazone and Humalog BASAL is considered.
To je treba upoštevati pri načrtovanju zdravljenja s kombinacijo pioglitazona in zdravila Humalog BASAL.
This should be strictly adhered to.
To je treba natančno upoštevati.
This should be taken into account by people on a controlled sodium diet.
To morajo upoštevati bolniki, ki so na dieti z nadzorovanim vnosom natrija.
This should be taken into account if you have diabetes.
To morate upoštevati, če imate sladkorno bolezen.
This should be taken into account if you have to follow a low sodium diet.
Ta podatek upoštevajte, če ste na dieti z nadzorovanim vnosom natrija.
This should be taken into account in patients on a low sodium diet.
To je treba upoštevati pri bolnikih na dieti z malo natrija.
This should be taken into account in patients on a sodium controlled diet.
To je treba upoštevati pri bolnikih na dieti z malo natrija.
This should be taken into account in patients with diabetes mellitus.
To morajo upoštevati bolniki, ki imajo sladkorno bolezen.
This should be taken into account when deciding on discontinuing Kineret during a severe infection.
To je treba upoštevati, ko se med hudo okužbo odločamo o prekinitvi zdravljenja z zdravilom Kineret.
This should be taken into account when interpreting BMD changes during treatment with PROTELOS.
Med razlaganjem sprememb mineralne kostne gostote ob zdravilu PROTELOS moramo omenjeno upoštevati.
This should be taken into account when prescribing HYCAMTIN, e.g. in case patients at increased risk of tumour bleeds are considered for therapy.
To je treba upoštevati pri predpisovanju zdravila Hycamtin, npr. pri bolnikih, pri katerih obstaja večje tveganje za pojav krvavitve tumorja.
This should be taken into account when prescribing HYCAMTIN, e.g. in case patients at increased risk of tumour bleeds are considered for therapy.
To morate upoštevati pri predpisovanju zdravila HYCAMTIN, če npr. razmišljate o zdravljenju bolnikov, ki imajo večje tveganje za tumorske krvavitve.
This should be taken into account when prescribing Topotecan Teva, e.g. in case patients at increased risk of tumour bleeds are considered for therapy.
To je treba upoštevati pri predpisovanju zdravila Topotekan Teva, npr. pri bolnikih, pri katerih obstaja večje tveganje za pojav krvavitve tumorja.
This should be taken into account when prescribing topotecan, e.g. in case patients at increased risk of tumour bleeds are considered for therapy.
To je treba upoštevati pri predpisovanju zdravila Potactasol, npr. pri bolnikih, pri katerih obstaja večje tveganje za pojav krvavitve tumorja.
This should be taken into account when prescribing topotecan, e.g. in case patients at increased risk of tumour bleeds are considered for therapy.
To morate upoštevati pri predpisovanju topotekana, na primer pri bolnikih z večjim tveganjem za krvavitve iz tumorja.
This should be taken into account, when prescribing topotecan, e.g. in case patients at increased risk of tumour bleeds are considered for therapy.
To je treba upoštevati pri predpisovanju zdravila Potactasol, npr. pri bolnikih, pri katerih obstaja večje tveganje za pojav krvavitve tumorja.
This should be taken into consideration by patients on a controlled sodium diet.
To je treba upoštevati pri bolnikih, ki potrebujejo prehrano z nadzorovano količino natrija.
This should be taken into consideration by patients on a controlled sodium diet.
To je treba upoštevati pri bolnikih, ki uživajo dieto z omejitvijo natrija.
This should be taken into consideration by patients on a controlled sodium diet.
To je treba upoštevati pri bolnikih, so na dieti z nadzorovanim vnosom natrija.
This should be taken into consideration by patients on a controlled sodium diet.
To naj upoštevajo bolnice, ki so na dieti z nadzorovanim vnosom natrija.
This should be taken into consideration for patients on a controlled sodium diet.
To je treba upoštevati pri bolnikih na dieti z nadzorovanim vnosom natrija.
This should be taken into consideration if you are on a controlled-sodium diet.
To je treba upoštevati, če ste na dieti z nadzorovanim vnosom natrija.
This should be taken into consideration if you are on a sodium controlled diet.
To morate upoštevati, če ste na dieti z nadzorovanim vnosom natrija.
This should be taken into consideration if you are on a strictly controlled sodium diet.
To morajo upoštevati bolniki, ki so na dieti z nadzorovanim vnosom natrija.
This should be taken into consideration while treating patients on controlled-sodium diet.
To je treba upoštevati pri zdravljenju bolnikov, ki so na dieti z nadzorovanim vnosom natrija.
This should be taken into consideration, particularly in patients with severe active disease at baseline not previously treated with TNFα antagonists. (See also section 5.1.)
To je treba upoštevati, še posebej pri bolnikih z močno aktivno boleznijo v izhodišču, ki se predhodno še niso zdravili z zaviralci tumorje nekrotizirajočega faktorja alfa (TNFα). (Glejte tudi poglavje 5.1.)
This should include data from ongoing studies, or actual use if applicable, of the ‘mock-up’ strains and any safety data relevant to the adjuvant system.
Vključeni morajo biti podatki o potekajočih študijah ali dejanski uporabi (če pride v poštev) "modelnega" seva in vsi podatki o varnosti, relevantni v zvezi z adjuvantnim sistemom.
This should include data from ongoing studies, or actual use if applicable, of the ‘mock-up’ strains and any safety data relevant to the adjuvant system.
Vključeni morajo biti podatki potekajočih študij ali, če je ustrezno, dejanske uporabe demonstracijskih sevov in podatkov o varnosti, pomembnih za adjuvantni sistem.
This should include data from ongoing studies, or actual use if applicable, of the ‘mock-up’ strains.
Tu morajo biti vključeni tudi podatki iz študij, ki so v teku, oziroma morebitni podatki iz dejanske uporabe ‘modelnih’ sevov cepiva.
This should include key messages regarding the need for regular blood and pregnancy tests and provide spaces for the dates of appointments and the results of tests.
Opozorilni kartonček za bolnika mora vključevati bistvene navedbe o potrebi po rednem izvajanju krvnih preiskav in testov nosečnosti ter mora imeti predvidene prostore za vpisovanje terminov in rezultatov opravljenih preiskav.
This should lead to a reduction in liver damage and an improvement in your liver function.
To naj bi vodilo do zmanjšanja okvare jeter in izboljšanja njihovega delovanja.
This should lead to an improvement in the safe and effective use of Cerezyme.
Na ta način se lahko izboljša varnost in učinkovitost uporabe zdravila Cerezyme.
This should take about 5 seconds.
To traja približno 5 sekund.
This should then be further diluted as follows: Slowly withdraw the reconstituted solution from each vial until the volume for the patient’s dose is obtained using a syringe with a needle diameter not larger than 20 gauge.
Nato je potrebno nadaljnje redčenje, kot je opisano v nadaljevanju: Počasi odvzemajte rekonstituirano raztopino iz vsake viale, dokler ne dosežete količine za bolnikov odmerek injekcije z uporabo injekcijske brizge z iglo premera največ 20 G (gauge).
This should then be further diluted as follows: Slowly withdraw the reconstituted solution from each vial until the volume for the patient’s dose is obtained.
Nato je potrebno nadaljnje redčenje, kot je opisano v nadaljevanju: Počasi odvzemajte rekonstituirano raztopino iz vsake viale, dokler ne dosežete količine za bolnikov odmerek.
This showed that antibodies against Pandemic influenza vaccine H5N1 MedImmune increased substantially when vaccinated adults came into contact with the virus again.
To je pokazalo, da so protitelesa proti cepivu proti pandemski gripi H5N1 MedImmune bistveno porasla, kadar so bili cepljeni odrasli ponovno izpostavljeni virusu.
This showed that Clopidogrel BMS reduces the risk of an event.
To je dokaz, da zdravilo Clopidogrel BMS znižuje tveganje za pojav dogodka.
This side effect is very rare (may affect up to 1 in 10,000 people).
Ta neželeni učinek je zelo redek (pojavi se lahko pri največ 1 bolniku od 10.000).
This slight temperature increase resolves spontaneously without treatment by day 5 post-vaccination.
Rahlo povišanje temperature se brez zdravljenja povrne na normalno vrednost do dne po cepljenju.
This slight temperature increase resolves spontaneously without treatment within 5 days.
Ta manjši dvig telesne temperature izzveni spontano, brez zdravljenja, v 5 dneh.
This slows down the growth and spread of the tumours.
Zaradi tega se rast in širjenje tumorja upočasnita.
This small increase in exposure did not result in a statistically significant difference in 24 hour serum cortisol levels between the two groups (see section 4.4).
To manjše povečanje izpostavljenosti ni imelo za posledico statistično pomembne razlike v 24-urnih vrednostih kortizola v serumu med obema skupinama (glejte poglavje 4.4).
This small volume of liquid is absorbed through the skin and has an effect throughout the animal’s body.
Ta majhna količina tekočine se absorbira skozi kožo in učinkuje na celotno telo živali.
This solution has to be drunk immediately.
Raztopino je treba popiti takoj.
This sometimes occurs together with discolouration of parts of the eye.
Spremembe barve se lahko včasih pojavijo skupaj s spremembami barve delov očesa.
This special chemistry facilitates rapid absorption at physiological pH and a long duration of action at the target tissue, the lung.
Ta kemijska posebnost omogoča izjemno hitro absorbcijo pri fiziološkem pH in dolgotrajno učinkovanje v ciljnem tkivu, pljučih.
This specialised medicine is used instead of autograft bone (some of a patient’s own bone taken from the hip) to fuse the spine.
To specializirano zdravilo se uporablja namesto avtolognega kostnega presadka (kadar se košček bolnikove kosti vzame iz kolka), da se hrbtenica zraste.
This staggered intake is the recommended administration for start of ticagrelor with a loading dose.
Takšno jemanje z zamikom je priporočeni način uporabe pri uvajanju ticagrelorja s polnilnim odmerkom.
This statistical signal was also confirmed in Eudravigilance, based on PRR analysis.
Statistični signal je bil prav tako potrjen s strani Eudravigilance, na osnovi analize razmerja proporcionalnega poročanja (PRR).
This step may be repeated until the correct amount of solution is in the syringe.
Ta korak lahko ponavljate, dokler ni v injekcijski brizgi ustrezne količine raztopine.
This step may be repeated until the correct amount of Water for Injections is in the syringe.
Ta korak lahko ponavljate, dokler ni v injekcijski brizgi ustrezne količine vode za injekcije.
This sticky label should be stuck on patient records.
To nalepko nalepite na kartoteko bolnika.
This stops the infection from spreading and gives the body’s natural defences a chance to completely get rid of the infection.
To ustavi širjenje okužbe in telesu omogoči naravno obrambo, da se popolnoma znebi okužbe.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent a heart attack or a stroke.
To preprečuje, da bi trombociti postali „lepljivi“, kar zmanjša tveganje za nastanek krvnega strdka in prispeva k preprečevanju srčnega infarkta ali kapi.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent a stroke or another heart attack.
Zaradi tega trombociti ne postanejo „lepljivi“, kar zmanjša tveganje za nastanek krvnega strdka in pripomore k preprečevanju kapi ali drugega srčnega infarkta.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent another heart attack or stroke.
To preprečuje, da bi trombociti postali lepljivi, s čimer zmanjšuje tveganje za nastanek krvnih strdkov in prispeva k preprečitvi novega srčnega napada ali možganske kapi.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent another heart attack or stroke.
To preprečuje, da bi trombociti postali lepljivi, ter tako zmanjšuje tveganje za nastanek krvnih strdkov in prispeva k preprečitvi novega srčnega napada ali kapi.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent another heart attack or stroke.
To preprečuje, da bi trombociti postali lepljivi, zmanjšuje tveganje za nastanek krvnih strdkov ter prispeva k preprečevanju novega srčnega napada ali kapi.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent another heart attack or stroke.
To preprečuje, da bi trombociti postali lepljivi, zmanjšuje tveganje za nastanek krvnih strdkov ter prispeva k preprečitvi novega srčnega napada ali kapi.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming and helping to prevent another heart attack or stroke.
To preprečuje, da bi trombociti postali „lepljivi“, ter tako zmanjšuje tveganje za nastanek krvnih strdkov in prispeva k preprečitvi novega srčnega napada ali kapi.
This stops the platelets becoming ‘sticky’, reducing the risk of a blood clot forming.
Zaradi tega trombociti ne postanejo „lepljivi“, kar zmanjša tveganje za nastanek krvnih strdkov.
This strong, deep breath pulls the medicinal product through the inhaler into your lungs.
S tem močnim, globokim vdihom povlečete zdravilo skozi inhalator v pljuča.
This study also compared Thyrogen with the patients’ own TSH.
V študiji so primerjali tudi zdravilo Thyrogen z bolnikom lastnim hormonom TSH.
This study also looked at the number of patients who had spine fractures over three years.
V tej študiji so proučevali tudi število bolnikov, pri katerih je v treh letih prišlo do zloma hrbtenice.
This study also looked at the proportion of patients who partially responded to treatment and whose cortisol level in the urine decreased by at least 50% after six months.
Poleg tega so v študiji preučevali tudi delež bolnikov, ki so se delno odzvali na zdravljenje in pri katerih se je koncentracija kortizola v urinu po šestih mesecih zmanjšala za vsaj 50 %.
This study also looked mainly at the percentage of patients who responded to treatment.
V študiji so merili predvsem delež bolnikov, ki so se na zdravljenje odzvali.
This study also showed that patients who received Cimzia had a greater reduction in the worsening of joint damage as seen on X-rays.
V tej študiji so poleg tega ugotovili, da se je napredovanje okvar sklepov, ugotovljeno na podlagi rentgenskih slik, bolj zmanjšalo pri bolnikih, ki so prejemali zdravilo Cimzia.
This study also showed that patients who received Simponi had greater improvements in carrying out everyday tasks.
Ta študija je tudi pokazala, da se je pri bolnikih, ki so prejemali zdravilo Simponi, sposobnost opravljanja vsakodnevnih opravil znatno izboljšala.
This study compared Avastin plus platinum-based chemotherapy with chemotherapy alone.
V študiji so učinke zdravila Avastin v kombinaciji s kemoterapijo z zdravili na osnovi platine primerjali s kemoterapijo kot edinim načinom zdravljenja.
This study compared Tarceva with placebo (a dummy treatment). a third study compared Tarceva with placebo in 643 patients with advanced NSCLC whose cancer cells did not have EGFR activating mutations and whose disease was stable after initial treatment with four cycles of platinum-containing chemotherapy.
V tej študiji so zdravilo Tarceva primerjali s placebom (zdravilom brez zdravilne učinkovine); v tretji študiji so zdravilo Tarceva primerjali s placebom pri 643 bolnikih z napredovalim nedrobnoceličnim pljučnim rakom, katerih rakave celice niso imele EGFR-aktivirajočih mutacij in katerih bolezensko stanje je bilo stabilno po začetnem zdravljenju s štirimi cikli kemoterapije na osnovi platine.
This study compares the risk of nomegestrol/estradiol use with the risk of levonorgestrel-containing combined oral contraceptive use.
Ta študija primerja tveganje uporabe nomegestrola/estradiola s tveganjem uporabe kombiniranih peroralnih kontraceptivov, ki vsebujejo levonorgestrel.
This study consisted of two phases, a placebo- controlled phase followed by a pre-planned follow-up phase.
Ta študija je imela dva dela: s placebom kontroliranemu prvemu delu je sledil vnaprej načrtovan kontrolni del študije.
This study demonstrated a significant reduction in transmission using single dose nevirapine (13.1 % (n = 310) in the nevirapine group, versus 25.1 % (n
V njej se je ta prenos pomembno zmanjšal po uporabi enkratnega odmerka nevirapina (13,1 % (n = 310) v skupini, ki je prejemala nevirapin, v primerjavi s 25,1 % (n =
This study did not show significant differences between Resolorand placebo at either dose, based on mean QT measurements and outlier analysis.
Študija ni pokazala pomembnih razlik med zdravilom Resolor in placebom v kateremkoli odmerku na podlagi povprečnih meritev QT in analize ubežnikov.
This study enrolled chemotherapy naïve patients who were asymptomatic or mildly symptomatic and for whom chemotherapy was not yet clinically indicated.
V študijo so vključili bolnike, ki še niso prejeli kemoterapije in niso imeli simptomov ali so imeli blage simptome, in bolnike, pri katerih kemoterapija še ni bila klinično indicirana.
This study evaluated the efficacy of Humira 40 mg every other week/methotrexate combination therapy, Humira 40 mg every other week monotherapy and methotrexate monotherapy in reducing the signs and symptoms and rate of progression of joint damage in rheumatoid arthritis for 104 weeks.
Ta študija je ocenila učinkovitost treh shem (kombinirano zdravljenje z zdravilom Humira 40 mg vsak drugi teden/metotreksatom, monoterapija z zdravilom Humira 40 mg vsak drugi teden in monoterapija z metotreksatom) za zmanjšanje znakov in simptomov ter hitrosti napredovanja sklepne okvare pri revmatoidnem artritisu v obdobju 104 tednov.